About This Study
This study is looking at the safety of a new study drug called ETX-636 for people with advanced cancer that has a change in the PIK3CA gene. Researchers also want to learn how well ETX-636 may work, either by itself or with another cancer treatment for certain types of breast cancer. This study is for volunteers diagnosed with a solid tumor that has a specific change in the PIK3CA gene that has spread or cannot be removed by surgery.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Use of Study Health Plans
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Study Visits and Consultations
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 100+ years old
- Female
- Male
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- Compensation Offered
- Reimbursement offered
Study Locations
- Greater Charlotte, NC